Immunolocalization of cell signaling molecules in the granular cell ameloblastoma

Journal of Oral Pathology and Medicine

Volumn 36, Issue 10, 2007, Pages 609-614

  Sathi, Gul San Ara ^a   Han, Phuu Pwint ^a   Tamamura, Ryo ^a   Nagatsuka, Hitoshi ^a   Hu, Hailong ^a   Katase, Naoki ^a   Nagai, Noriyuki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Ameloblastoma; Granular cell; Signaling molecules

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN 4; HEPARAN SULFATE; HEPARANASE; PARAFFIN; WNT2 PROTEIN; WNT5A PROTEIN;

AMELOBLASTOMA; ARTICLE; BASEMENT MEMBRANE; CELL SURFACE; CELL TYPE; GRANULAR CELL TUMOR; IMMUNOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; UPREGULATION;

AMELOBLASTOMA; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEINS; GLUCURONIDASE; HEPARITIN SULFATE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTO-ONCOGENE PROTEINS; WNT PROTEINS;

EID: 35348962036     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2007.00580.x     Document Type: Article

References (33)

1. Nasu M, Takagi M, Yamamoto H. Ultrastructural and histochemical studies of granular cell ameloblastoma. J Oral Pathol 1984 13: 448 56.
2. Shafer WG, Hine MK, Levy BM. A textbook of oral pathology. Philadelphia: W.B. Saunders Co., 1983 276 86.
3. Dina R, Marchetti C, Vallania G, Corinaldesi G, Eusebi V. Granular cell ameloblastoma: an immunocytochemical study. Pathol Res Pract 1996 192: 541 6.
4. Parkinson-Lawrence E., Fuller M, Hopwood JJ, Meikle PJ, Brooks DA. Immunochemistry of lysosomal storage disorders. Clin Chem 2006 52: 1660 8.
5. Regezi JA, Zarbo RJ, Courtney RM, Crissman JD. Immunoreactivity of granular cell lesions of skin, mucosa, and jaw. Cancer 1989 64: 1455 60.
6. Mirchandani R, Sciubba JJ, Mir R. Granular cell lesions of the jaws and oral cavity: a clinicopathologic, immunohistochemical, and ultrastructural study. J Oral Maxillofac Surg 1989 47: 1248 55.
7. Fukumashi K, Enokiya Y, Inoue T. Cytokeratins expression of constituting cells in ameloblastoma. Bull Tokyo Dent Coll 2002 43: 13 21.
8. Kumamoto H, Ooya K. Immunohistochemical and ultrastructural investigation of apoptotic cell death in granular cell ameloblastoma. J Oral Pathol Med 2001 30: 245 50.
9. Eaton S. Release and trafficking of lipid-linked morphogens. Curr Opin Genet Dev 2006 16: 17 22.
10. Etheridge SL, Spencer GJ, Heath DJ, Genever PG. Expression profiling and functional analysis of Wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 2004 22: 849 60.
11. Cheng XX, Wang ZC, Chen XY, et al. Correlation of Wnt-2 expression and beta-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination. Cancer Lett 2005 223: 339 47.
12. Dashwood WM, Carter O, Al-Fageeh M, Li Q, Dashwood RH. Lysosomal trafficking of beta-catenin induced by the tea polyphenol epigallocatechin-3- gallate. Mutat Res 2005 591: 161 72.
13. You L, He B, Xu Z, et al. Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 2004 23: 6170 4.
14. Do Prado RF, Consolaro A, Taveira LA. Expression of betacatenin in carcinoma in pleomorphic adenoma, pleomorphic adenoma and normal salivary gland: an immunohistochemical study. Med Oral Pathol Oral Cir Bucal 2006 11: E247 51.
15. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 2003 162: 899 908.
16. Kumamoto H, Ooya K. Immunohistochemical detection of beta-catenin and adenomatous polyposis coli in ameloblastomas. J Oral Pathol Med 2005 34: 401 6.
17. Yamaguchi A, Komori T, Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 2000 21: 393 411.
18. Bellusci S, Henderson R, Winnier G, Oikawa T, Hogan BL. Evidence from normal expression and targeted misexpression that bone morphogenic protein-4 (BMP-4) plays a role in mouse embryonic lung morphogenesis. Development 1996 122: 1693 702.
19. Yoshikawa H, Rettig WJ, Takaoka K, et al. Expression of bone morphogenetic proteins in human osteosarcoma: immunohistochemical detection with monoclonal antibody. Cancer 1994 73: 85 91.
20. Katoh M, Terada M. Overexpression of bone morphogenic protein (BMP)-4 mRNA in gastric cancer cell lines of poorly differentiated type. J Gastroenterol 1996 31: 137 9.
21. Kumamoto H, Ooya K. Expression of bone morphogenic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors. Oral Dis 2006 12: 163 70.
22. Jasuja R, Allen BL, Pappano WN, Rapraeger AC, Greenspan DS. Cell-surface heparan sulfate proteoglycans potentiate chordin antagonism of bone morphogenetic protein signaling and are necessary for cellular uptake of chordin. J Biol Chem 2004 279: 51289 97.
23. Vlodavsky I, Goldshmidt O, Zcharia E, et al. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin Cancer Biol 2002 12: 121 9.
24. van den Born J, Salmivirta K, Henttinen T, et al. Novel heparan sulfate structures revealed by monoclonal antibodies. J Biol Chem 2005 280: 20516 23.
25. David G, Bai XM, van der Schueren B, Cassiman JJ, van den Berghe H. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol 1992 119: 961 75.
26. Han PP, Nagatsuka H, Siar CH, et al. Immunodetection of heparan sulphate and heparanase molecules in benign and malignant odontogenic tumors. J Oral Med Pathol 2006 11: 49 54.
27. Parish CR, Freeman C, Hulett MD. Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 2001 1471: M99 108.
28. Nagatsuka H, Han PP, Tsujigiwa H, et al. Heparanase gene and protein expression in ameloblastoma: possible role in local invasion of tumor cells. Oral Oncol 2005 41: 542 8.
29. Zetser A, Levy-Adam F, Kaplan V, et al. Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci 2004 117: 2249 58.
30. Kurayoshi M, Oue N, Yamamoto H, et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 2006 66: 10439 48.
31. Westendorf JJ, Kahler RA, Schroeder TA. Wnts signaling in osteoblasts and bone diseases. Gene 2004 341: 19 39.
32. Kusafuka K, Yamaguchi A, Kayano T, Fujiwara M, Takemura T. Expression of bone morphogenetic proteins in salivary pleomorphic adenomas. Virchows Arch 1998 432: 247 53.
33. Jin Y, Tipoe GL, Liong EC, Lau TY, Fung PC, Leung KM. Overexpression of BMP-2/4,-5 and BMPR-IA associated with malignancy of oral epithelium. Oral Oncol 2001 37: 225 33.